SRPT - Sarepta Therapeutics,, Inc. Common Stock

SRPT

$20.86 0.73 (-3.38%) Last updated: Aug 29, 2026 12:18

52-Week Range

$20.86

$14.68 $20.86 $25.32

Fundamentals Overview

Sarepta Therapeutics,, Inc. Common Stock is in the middle of its 52-week range, trending downward today.

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 35% confidence Risk: Diversify and only invest what you can afford to lose.

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$2.20B

P/E (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$14.68 - $25.32

Volume vs Avg

N/A

About

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in o...

Sector: stocks

Headquarters:

Website: www.sarepta.com

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	N/A
PEG (TTM)	N/A
P/B (TTM)	N/A
P/S (TTM)	N/A
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	N/A
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SRPT.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.